register

News & Trends - Pharmaceuticals

Newly launched Parliamentary Friends Group to keep cystic fibrosis community front of mind

Health Industry Hub | March 31, 2023 |

Pharma News: Yesterday marked the official launch of the Parliamentary Friends of Cystic Fibrosis Group. Cystic Fibrosis Australia was honoured to be a part of this event and advocate for the CF community as part of the national patient voice.

Chairs Dr Michael Freelander MP, Monique Ryan MP and Bridget Archer MP shared why the establishment of this group is crucial for the CF community.

Cystic Fibrosis Australia, CEO, Jo Armstrong, said “The establishment of the Cystic Fibrosis Friendship Group is a significant step in ensuring that the cystic fibrosis community is heard by our nation’s leaders. There are a range of critical issues impacting the community and together we can seek progress so that all Australians living with cystic fibrosis can have longer, healthier lives.

“CFA also acknowledges the many Parliamentarians who attended for their support of Cystic Fibrosis. Thank you also to the clinicians, researchers, federation members, friends, family, and community members who attended.”

Cystic Fibrosis Australia has been calling on the Federal Health Minister, Mark Butler “to do all that he can to accelerate the listing of Vertex’s Trikafta” for 6-11 age group.

Liberal Senator Kerrynne Liddle said in Parliament earlier this week “In November last year the PBAC recommended that the innovative drug Trikafta be added to the PBS for treatment of children, with cystic fibrosis, aged 6 to 11 years. However, government has, so far, failed to add this life-changing medicine to the PBS, despite the months that have passed since it was recommended.

“The government must do the right thing by the 500 children with cystic fibrosis who would benefit from affordable access to this life-changing medicine and list this medicine on the PBS.”

Sabrina Barbic, Senior Country Manager, Vertex Pharmaceuticals said “We are thrilled to be at Parliament House alongside the patient community to support the launch of the Australian Parliamentary Friends of Cystic Fibrosis Group.”

Over 1 million Australians have the cystic fibrosis gene. Every 4 days a baby is born in Australia with cystic fibrosis.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.